Bill Langbein Archives | GeoInvesting

August 6, 2023

SanaCurrents on Crinetics’ (CRNX) paltusotine to treat acromegaly

This content is for members only

July 30, 2023

China-based Hutchmed’s (HCM) colorectal cancer may soon enter US if PDUFA is approved

This content is for members only

June 26, 2023

SanaCurrents on COYA Thera’s (COYA) Treg approach to treat ALS

This content is for members only

June 18, 2023

SanaCurrents on Ventyx’s (VTYX) rising phase II entry to treat ulcerative colitis (UC)

This content is for members only

June 10, 2023

SanaCurrents on Ventyx’s (VTYX) rising phase II entry to treat ulcerative colitis (UC)

This content is for members only

May 19, 2023

SanaCurrents on Structure Thera’s (GPCR) new oral drug for Type II diabetes

This content is for members only

May 13, 2023

SanaCurrents on the FDA decision for Ocuphire’s (OCUP) Nyxol eye drops for consumers

This content is for members only

May 6, 2023

SanaCurrents on Immatics (IMTX) promising immunotherapy data to treat solid tumors

This content is for members only